The findings support the hypothesis that rosacea may be associated with an increased risk of IBS, potentially mediated by systemic inflammatory pathways and neurological interactions as suggested by the gut-skin axis. This indicates that gastrointestinal symptoms and diseases should be considered when managing rosacea patients. Further studies are needed to explore the underlying mechanisms of this association and to confirm these findings in other populations.